Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New York Daily Ledger.
Press releases published on June 2, 2025
Cemtrex’s Vicon Expands Leadership in UK Prison Security Market with New Wave of System Orders
GlobeNewswire
·
June 2, 2025
Hauppauge, NY, June 02, 2025 (GLOBE NEWSWIRE) -- Vicon Industries, a subsidiary of Cemtrex Inc. (Nasdaq: CETX) and a leading provider of advanced security and surveillance solutions, today announced it has secured a new set of significant orders from …
Safehold Special Risk Launches New Specialized Equipment Coverage Program
GlobeNewswire
·
June 2, 2025
CARROLLTON, Ga., June 02, 2025 (GLOBE NEWSWIRE) -- Safehold Special Risk, Inc. (“Safehold”), a division of Innovation Growth Partners Specialty, LLC, has launched a new specialized equipment coverage program in partnership with Concert Specialty Insurance …
Notified Launches Personalized Pitch to Help PR Pros Drive More Media Coverage
GlobeNewswire
·
June 2, 2025
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Notified has launched Personalized Pitch - a smart new feature built with the feedback of public relations professionals to help teams land more coverage, faster. With the challenges facing communicators - …
AmpliTech Group To Participate In The “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow” Virtual Conference Presented By Maxim Group LLC
GlobeNewswire
·
June 2, 2025
HAUPPAUGE, N.Y., June 02, 2025 (GLOBE NEWSWIRE) -- AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a leading designer, developer, and manufacturer of advanced signal processing components for satellite, public and private 5G, and other communications networks …
Liberation Labs is Now Liberation Bioindustries
GlobeNewswire
·
June 2, 2025
RICHMOND, Ind., June 02, 2025 (GLOBE NEWSWIRE) -- Liberation Labs has a new name and brand – Liberation Bioindustries. The name and brand refresh better reflect the company’s position as a global, commercial-scale, contract biomanufacturer. The company’s …
CIVI STOCK: Suffer Losses on Civitas Resources, Inc.? BFA Law Notifies Investors of Imminent July 8 Securities Class Action Deadline (NYSE:CIVI)
GlobeNewswire
·
June 2, 2025
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …
ELV STOCK: Suffer Losses on Elevance Health, Inc.? BFA Law Notifies Investors of Imminent July 11 Securities Class Action Deadline (NYSE:ELV)
GlobeNewswire
·
June 2, 2025
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …
IOVA STOCK: Suffer Losses on Iovance Biotherapeutics, Inc.? BFA Law Notifies Investors of Imminent July 14 Securities Class Action Deadline (NASDAQ:IOVA)
GlobeNewswire
·
June 2, 2025
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …
CODI STOCK: Suffer Losses on Compass Diversified Holdings? BFA Law Notifies Investors of Imminent July 8 Securities Class Action Deadline (NYSE:CODI)
GlobeNewswire
·
June 2, 2025
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …
OGN STOCK: Suffer Losses on Organon & Co.? BFA Law Notifies Investors of Imminent July 22 Securities Class Action Deadline (NYSE:OGN)
GlobeNewswire
·
June 2, 2025
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …
URGN STOCK: Suffer Losses on UroGen Pharma Ltd.? BFA Law Notifies Investors of Imminent July 28 Securities Class Action Deadline (NASDAQ:URGN)
GlobeNewswire
·
June 2, 2025
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …
VTRS STOCK DEADLINE TOMORROW: Suffer Losses on Viatris Inc.? BFA Law Notifies Investors of Imminent June 3 Securities Class Action Deadline (NASDAQ:VTRS)
GlobeNewswire
·
June 2, 2025
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …
RDDT STOCK: Suffer Losses on Reddit, Inc.? BFA Law Notifies Investors of Pending Securities Fraud Investigation (NYSE:RDDT)
GlobeNewswire
·
June 2, 2025
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti …
Worksport Surpasses Monthly Sales Record in April on Strong AL4 Performance
GlobeNewswire
·
June 2, 2025
AL4 Drives 40% of Sales Within Weeks of Launch; Application Rollout Nearing Completion with Significant Growth Expected to Continue West Seneca, New York, June 02, 2025 (GLOBE NEWSWIRE) -- Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a U.S …
New York Mortgage Trust, Inc. Announces Consent Solicitation Related to Senior Notes due 2026 to Support Strategic Growth
GlobeNewswire
·
June 2, 2025
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- New York Mortgage Trust, Inc. (Nasdaq: NYMT) (“NYMT” or the “Company”) today announced that it is soliciting consents (the “Consent Solicitation”) from holders of its outstanding 5.75% Senior Notes due 2026 (the …
Catalyst Continues Growth with Hirings of Institutional Relations and Portfolio Strategist Professionals
GlobeNewswire
·
June 2, 2025
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Catalyst Capital Advisors LLC, a leading provider of alternative and innovative investment solutions, today announced the hire of Robert Gallant, CFA, CAIA, as Executive Director of Institutional Relations, and …
NewtekOne, Inc. to Report Second Quarter 2025 Results and Host a Conference Call on Monday, July 28, 2025
GlobeNewswire
·
June 2, 2025
BOCA RATON, Fla., June 02, 2025 (GLOBE NEWSWIRE) -- NewtekOne, Inc. (the “Company”) (NASDAQ: NEWT) will report its second quarter 2025 financial results after the market closes on Monday, July 28, 2025. A conference call to discuss these results will be …
SELLAS Presents Preclinical Efficacy of SLS009 in ASXL1 Mutated Colorectal Cancer at 2025 ASCO Annual Meeting
GlobeNewswire
·
June 2, 2025
- ASCO Presentation Supports SLS009 as a Potential Targeted Therapy for ASXL1 Mutated Colorectal Cancer – - 22,500 New Cases of Colorectal Cancer with High Microsatellite Instability per Year in the US: 55% ASXL1m Frequency – NEW YORK, June 02, 2025 (GLOBE …
Indaptus Therapeutics Doses First Patient in Phase 1b/2 Combination Study of Decoy20 with PD-1 Checkpoint Inhibitor Tislelizumab
GlobeNewswire
·
June 2, 2025
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical-stage biotechnology company dedicated to developing novel treatments for cancer and viral infections, announces that the first patient has been dosed in the …
TG Therapeutics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
·
June 2, 2025
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the Jefferies Global Healthcare Conference, being held at the …